Norges Bank’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Norges Bank’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-150,500	Closed	-$6.21M	–	2369
2015 Q2	$6.21M	Sell	150,500 -7,800	-5%	-$280K	﹤0.01%	1838
2015 Q1	$5.58M	Sell	158,300 -37,387	-19%	-$1.26M	﹤0.01%	1872
2014 Q4	$6.29M	Sell	195,687 -101,146	-34%	-$2.93M	﹤0.01%	1840
2014 Q3	$8.33M	Sell	296,833 -296,833	-50%	-$9.04M	﹤0.01%	1684
2014 Q2	$17.9M	Buy	593,666 +296,833	+100%	+$8.19M	﹤0.01%	1677
2014 Q1	$8.22M	Hold	296,833	–	–	﹤0.01%	1675
2013 Q4	$7.58M	Buy	296,833 +13,177	+5%	+$406K	﹤0.01%	1722
2013 Q3	$8.48M	Hold	283,656	–	–	﹤0.01%	1654
2013 Q2	$8.15M	Buy	+283,656	New	+$7.82M	0.01%	1597

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Norges Bank's BRLI Position: Q3 2015 in Review

Norges Bank sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 150,500 shares — an estimated $6.21M sold.

Norges Bank first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $17.9M in Q2 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Norges Bank reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Norges Bank sold 150,500 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $6.21M.
Norges Bank first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Norges Bank's BIO-REFERENCE LABS INC-NEW- position peaked at $17.9M in Q2 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Norges Bank's 13F filing for Q3 2015, filed 6 Nov 2015.